Poly (ADP-Ribose) Polymerase 2 (PARP2) (C-Term) Peptide
PARP2
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN2181971
Aperçu rapide pour Poly (ADP-Ribose) Polymerase 2 (PARP2) (C-Term) Peptide (ABIN2181971)
Antigène
PARP2
(Poly (ADP-Ribose) Polymerase 2 (PARP2))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Séquence
- QCNELLEANP KAEGLLQGKH STKGLGKMAP SSAHFVTLNG STVPLGPASD
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PARP2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
Poly (ADP-Ribose) Polymerase 2 (PARP2) peptide
PARP2 Reactivité: Humain Hôte: Synthetic BP, Imm
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeat freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PARP2 (Poly (ADP-Ribose) Polymerase 2 (PARP2))
-
Sujet
-
PARP2 is involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks.
Alias Symbols: ADPRT2, ADPRTL2, ADPRTL3, ARTD2, PARP-2, pADPRT-2
Protein Size: 570 -
Poids moléculaire
- 62 kDa
-
ID gène
- 10038
-
NCBI Accession
- NM_001042618, NP_001036083
Antigène
-
Vous êtes ici:
